Marked enhancement of clinical efficacy of platelet GP IIb/IIIa blockade with c7E3 fab (Abciximab) linked to reduction in bleeding complications: Outcome in the EPILOG and EPIC trials

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Lincoff, AM; Tcheng, JE; Miller, DP; Booth, JE; Montague, EA; Topol, EJ

Published Date

  • October 15, 1996

Published In

Volume / Issue

  • 94 / 8

Start / End Page

  • 2185 - 2185

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 0009-7322

Language

  • English